• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

MRSA - Articles and news items

Eczema wounds diseased by S. aureus contamination

Industry news / 5 August 2016 / Erasmus MC University

A new study has revealed that 70% of eczema patients are colonised with Staphylococcus aureus bacteria (S. aureus, including MRSA) on their skin lesions…

MRSA treatment market to experience limited growth, says GlobalData

Industry news / 5 January 2016 / Victoria White

The minimal increase over the next decade will be largely the product of a treatment space dominated by three primary agents, namely vancomycin, Zyvox (linezolid), and Cubicin (daptomycin)…

Aridis expands Phase 2a trial of AR-301 into the US

Industry news / 9 July 2015 / Victoria White

The US Food and Drug Administration (FDA) has accepted Aridis Pharmaceuticals’ Investigational New Drug (IND) application for AR-301 (Salvecin)…


Changing the way we combat bacterial infections: Dutch biotech Micreos launches first bacteria-killing enzyme for human use against MRSA

Industry news / 5 November 2014 / Micreos

Micreos, a Dutch biotech company, has developed Staphefekt™, a bacteria-killing enzyme specific to Staphylococcus aureus, which is equally effective in killing methicillin-resistant Staphylococcus aureus (MRSA) as methicillin-susceptible Staphylococcus aureus (MSSA)…

Professor Dame Sally Davies, England’s Chief Medical Officer

Antimicrobial resistance poses ‘catastrophic threat’

Industry news, News / 12 March 2013 / Department of Health

Chief Medical Officer says global action is needed otherwise in 20 years we could see any one of us dying following minor surgery…